Oncology Compass

Advanced Prostate Cancer Consensus Conference (APCCC) 2025 will start tomorrow. The diagnostic abilities for assessing prostate cancer patients have significantly evolved in the last years. Ranging from advanced imaging modalities for detection, new innovative liquid and tissue-based biomarkers, and the recent introduction of PSMA PET imaging have significantly advanced the field, challenging some of the old grounds of truth. The introduction of the Advanced Prostate Cancer Consensus Conference (APCCC) in 2015 represents a milestone in establishing clinical consensus in the care of advanced #prostatecancer patients. While the diagnostic part was always an essential part of the APCCC series, its growing importance for earlier stages and detection cannot be adequately addressed in such a format. Accordingly, APCCC's initiators and leading diagnostic experts have agreed to spin out a conference series dedicated to prostate cancer diagnostics: #APCCC diagnostics. If you would like to find information on similar events in one place, visit our Calendar of medical conferences, where you can filter events by date, location and cancer indications: https://lnkd.in/dnnmN4hD

The history of esophageal cancer dates back to 3000 BC, as recorded in written forms discovered by American Egyptologist Edwin Smith in 1862. This disease was also documented in the works of Chinese and Arab-Islamic physicians. For centuries, oesophageal cancer was considered untreatable. A major breakthrough came in 1868 when Adolf Kussmaul introduced the esophagoscope, enabling direct observation of the esophagus. Surgical advancements followed: 🔹 1877 – Vincenz Czerny performed the first successful resection of the cervical esophagus due to carcinoma. 🔹 1913 – Franz Torek completed the first successful subtotal thoracic esophagectomy. 🔹 1913 – Tohru Ohsawa introduced the first esophagectomy with an intrathoracic esophagogastric anastomosis. Over the last century, significant progress has been made in diagnosing and treating esophageal cancer. Encouraging proactive health choices, regular screenings, and lifestyle adjustments can play a vital role in reducing the risk of oesophageal cancer and improving overall well-being. #EsophagealCancerAwarenessMonth #Oncology #OncologyCompass

🚀 Advancing the Future of Targeted Therapies in Lung Cancer The landscape of lung cancer treatment is constantly evolving, and the IASLC 2025 Targeted Therapies of Lung Cancer (TTLC) meeting is where the latest breakthroughs take centre stage. 📆 February 19-22, 2025 🔹Huntington Beach, California. This global event will bring together leading oncologists, researchers, and industry experts to discuss cutting-edge innovations in precision medicine, biomarker-driven treatments, and the next generation of targeted therapies. 🔬 Expect insights on novel therapeutic strategies, clinical trials, and real-world applications that are shaping the future of lung cancer care. If you would like to find information on similar events in one place, visit our Calendar of medical conferences, where you can filter events by date, location and cancer indications: https://lnkd.in/dnnmN4hD #IASLC #TTLC2025 #LungCancer #TargetedTherapies #Oncology #PrecisionMedicine #HealthcareInnovation

Come together with us at the 2025 ASCO Annual Meeting. Embrace new opportunities and new connections with colleagues from around the world, immerse yourself in cutting-edge scientific research and discoveries, and add your voice to conversations that will transform tomorrow’s outcomes. Register today: https://brnw.ch/21wQEfp

On World Cancer Day, we highlight the importance of early detection and prevention in the fight against cancer. It is a battle shared by many, yet deeply personal for each individual. No one should face it alone. This year’s theme, United by Unique, underscores the power of personalised care—placing people at the centre of cancer treatment and their stories at the heart of the conversation. Timely screenings, awareness, and lifestyle changes can save lives by identifying cancer in its earliest stages when treatment is most effective. Raise awareness. Take action. Global efforts today lead to a healthier tomorrow. 💜 #WorldCancerDay #OncologyCompass #Capptoo #CancerAwareness #PatientCare

Fight Colorectal Cancer is a leading national patient empowerment and advocacy organization in the United States dedicated to serving the colorectal cancer community. Since its founding in 2005, the organization has been committed to improving access to health information, enhancing screening procedures, and securing increased funding for colorectal cancer research. Oncology Compass spoke with Molly McDonnell, Vice President of Advocacy, to learn more about their ongoing efforts to drive change. Read more here: https://lnkd.in/dfGwg2jY #oncology #healthcare #cancerfight

Tomorrow starts the 2025 ASCO GI Cancers Symposium. It offers the latest innovative science, solution-focused strategies, and multidisciplinary approaches in GI cancer treatment, research, and care. If you would like to find information on similar events in one place, visit our Calendar of medical conferences, where you can filter events by date, location and cancer indications: https://lnkd.in/dnnmN4hD #oncology #GI25

With every new issue of our Oncology Compass Digest, while reading these stories, I’m reminded once again of why we do what we do. Behind every headline and breakthrough article are real people navigating life with immense courage and strength. 💖 This issue features two powerful stories that are close to my heart: 🌟 Christina Christen, President of Europa Donna Switzerland, whose passion and commitment fuel the fight for breast cancer justice in Switzerland. 🌟 Jo Knight, a breast cancer warrior on a mission to transform the lives of cancer patients. If you’re an oncologist or know someone in the oncology field, I invite you to explore Oncology Compass. You can read the full issue here: https://lnkd.in/gRhAmpcP #OncologyCompass #BreastCancerAwareness #Oncology #PatientAdvocacy

📰 The first Oncology Compass Digest of 2025 is available! 🔍 Inside This Issue: 📖 Feature Story: Christina Christen, President of #EuropaDonna Switzerland, shares her inspiring efforts to raise awareness about breast cancer and early detection. ℹ️ Lobbying for Change: Jo Knight, a breast cancer survivor, is transforming lives by advocating for solutions that bring dignity and comfort to cancer patients facing chemotherapy-related hair loss. ℹ️Robotics and Reality: An expert interview explores how robotics simulation training can play a crucial role in addressing the shortage of skilled surgeons in gynecologic oncology. ℹ️Oncology Breakthroughs: Discover the latest insights from the PACIFIC-2 trial on durvalumab with chemoradiation. 📌 Explore Digest #12 now: https://lnkd.in/dibCCPBT #OncologyCompass #CancerResearch #PatientCare #BreastCancer

This week, we showcase the OlympiA Phase III trial, which reveals that adjuvant olaparib significantly boosts overall survival in patients with germline BRCA1/2 mutations and high-risk, HER2-negative early breast cancer, compared to placebo. This improvement comes without new safety concerns, affirming olaparib's role in enhancing survival and disease-free outcomes for this patient group. The study was selected by Prof. Dr. Jens Huober, one of the Oncology Compass Scientific Leaders, and can be found here: https://lnkd.in/ddyufFkK